Emerging Biomarkers in Glioblastoma

Glioblastoma, the most common primary brain tumor, has few available therapies providing significant improvement in survival. Molecular signatures associated with tumor aggressiveness as well as with disease progression and their relation to differences in signaling pathways implicated in gliomagene...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Mairéad G., Sahebjam, Solmaz, Mason, Warren P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795381/
https://www.ncbi.nlm.nih.gov/pubmed/24202336
http://dx.doi.org/10.3390/cancers5031103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795381/
https://www.ncbi.nlm.nih.gov/pubmed/24202336
http://dx.doi.org/10.3390/cancers5031103

Ejemplares similares